UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

For the past couple of years, clinicians have been singing the praises of generative AI-powered clinical documentation tools, saying that these models give them hours back into their day.

Organizations across the entire healthcare ecosystem have been betting big on AI. The excitement is justified. Implementing these technologies can save a lot of time and money to do a lot of ...

Social determinants of health (SDOH) screening tools have been prioritized in emerging healthcare delivery models aimed at transforming traditional care delivery and reimbursing a broader bench of ...

Priority Health, a nonprofit health plan, is teaming up with Ayble Health to provide digestive health support to its members, the companies announced on Wednesday. Grand Rapids, Michigan-based ...

On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test. The company, named Teal Health, was founded in 2020 and has raised $23 million.

Bringing a new drug to market is staggeringly inefficient: About 90% of new drugs fail in clinical trials, development times are 10-15 years, and the costs can run in excess of $2 billion dollars.

Finding a caregiver who meets your care needs and schedule requires planning and the right tools. Flexible caregiving is key for those with changing routines, shift work or evolving health needs.

Representative clinical studies are important as diseases and medicines can affect people differently depending on their age, sex, and race and ethnicity. According to the Food and Drug ...

A rare type of ovarian cancer that grows slowly and responds poorly to chemotherapy now has its first FDA-approved treatment, a combination drug developed by Verastem Oncology to address a pathway ...

Withings Health Solutions and Babyscripts announced a partnership Thursday that aims to address hypertensive disorders of pregnancy, which are among the leading causes of maternal mortality.